118 related articles for article (PubMed ID: 3879855)
1. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
Boon T; Maryanski J
Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Maryanski JL; Boon T
Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
Maryanski JL; Van Snick J; Cerottini JC; Boon T
Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
[TBL] [Abstract][Full Text] [Related]
5. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
Fuji H; Iribe H
Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
[TBL] [Abstract][Full Text] [Related]
6. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
7. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma.
Zbar B; Sukumar S; Tanio Y; Terata N; Hovis J
Cancer Res; 1984 Nov; 44(11):5079-85. PubMed ID: 6488168
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
Maryanski JL; Szpirer J; Szpirer C; Boon T
Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
Uyttenhove C; Van Snick J; Boon T
J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
Maryanski JL; Marchand M; Uyttenhove C; Boon T
Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
[TBL] [Abstract][Full Text] [Related]
11. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens.
Altevogt P; von Hoegen P; Leidig S; Schirrmacher V
Cancer Res; 1985 Sep; 45(9):4270-7. PubMed ID: 4028013
[TBL] [Abstract][Full Text] [Related]
12. Identification of tumour rejection antigens recognized by T lymphocytes.
Boon T; De Plaen E; Lurquin C; Van den Eynde B; van der Bruggen P; Traversari C; Amar-Costesec A; Van Pel A
Cancer Surv; 1992; 13():23-37. PubMed ID: 1423324
[TBL] [Abstract][Full Text] [Related]
13. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815.
Marchand M; Caspar P; Boon T
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1529-37. PubMed ID: 6196202
[TBL] [Abstract][Full Text] [Related]
15. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
Gorelik E; Peppoloni S; Overton R; Herberman RB
Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.
Vessière F; Georlette M; Warnier G; Leclerc JC; Van Pel A; Boon T
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):867-74. PubMed ID: 6185345
[TBL] [Abstract][Full Text] [Related]
17. Mutagen-induced antigenic variants of tumor cells.
Boon T; Van Pel A; De Plaen E; Vessière F
Symp Fundam Cancer Res; 1986; 38():139-48. PubMed ID: 3489258
[No Abstract] [Full Text] [Related]
18. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
Wölfel T; Van Pel A; De Plaen E; Lurquin C; Maryanski JL; Boon T
Immunogenetics; 1987; 26(3):178-87. PubMed ID: 3114137
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
